The Utility of Comprehensive Metabolic Panel Tests for the Prediction of Bronchopulmonary Dysplasia in Extremely Premature Infants
Table 5
Effect of BUN on BPD and other neonatal morbidities.
Morbidities
(110)
(119)
value
OR (95% CI)
BPD
20 (18.2%)
50 (42.0%)
1.182
3.261 (1.779, 5.978)
PAH
3 (2.7%)
13 (10.9%)
1.488
0.024
4.430 (1.221, 16.069)
Intervened ROP
6 (5.5%)
20 (16.8%)
5.952
0.012
3.468 (1.319, 9.118)
IVH (grade III or IV)
3 (2.7%)
15 (12.6%)
3.535
0.012
5.049 (1.419, 17.962)
Intubated days
0.4 (0.0, 3.0)
1.9 (0.0, 18.0)
-3.155
0.002
—
nCPAP days
16.0 (7.5, 28.5)
21.2 (8.2, 32.0)
-1.191
0.234
—
Hospital stays
76.0 (65.0, 95.7)
79.0 (67.5, 109.0)
-1.672
0.094
—
Data were displayed as median (interquartile range) or number (percentage). BPD: bronchopulmonary dysplasia; PAH: pulmonary hypertension; ROP: retinopathy of prematurity; IVH: intraventricular hemorrhage; nCPAP: nasal continuous positive airway pressure.
